China Pharma Holdings/$CPHI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About China Pharma Holdings
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
- Ticker
- $CPHI
- Sector
- Health
- Primary listing
- AMEX
- Employees
- -
- Headquarters
- Haikou, China
- Website
- www.chinapharmaholdings.com
CPHI Metrics
BasicAdvanced
$30M
-
-$0.23
1.07
-
Price and volume
Market cap
$30M
Beta
1.07
52-week high
$19.19
52-week low
$0.38
Average daily volume
3.2M
Financial strength
Current ratio
0.261
Quick ratio
0.072
Long term debt to equity
0.002
Total debt to equity
0.112
Interest coverage (TTM)
-44.19%
Profitability
EBITDA (TTM)
-1.441
Gross margin (TTM)
11.76%
Net profit margin (TTM)
-114.33%
Operating margin (TTM)
-111.82%
Management effectiveness
Return on assets (TTM)
-9.36%
Return on equity (TTM)
-20.99%
Valuation
Price to revenue (TTM)
3.407
Price to book
0.78
Price to tangible book (TTM)
-13.1
Price to free cash flow (TTM)
-60.756
Free cash flow yield (TTM)
-1.65%
Free cash flow per share (TTM)
-0.011
Growth
Revenue change (TTM)
-10.97%
Earnings per share change (TTM)
-83.60%
3-year revenue growth (CAGR)
-21.02%
10-year revenue growth (CAGR)
-13.22%
3-year earnings per share growth (CAGR)
-78.34%
10-year earnings per share growth (CAGR)
-44.64%
CPHI Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.